Board
The Interpharma Board determines the strategic direction of the association and represents the interests of research-based pharmaceutical companies in Switzerland.
Jörg-Michael Rupp 1
President
Director Pharma International – Roche
Sabine Bruckner 1
Vice-President
Country Manager Switzerland – Pfizer
Leila Schwery 1
Vice-President
VP Manufacturing & Technical Operations – Johnson & Johnson
Iris Zemzoum 1, 2
Vice-President
President Region Europe – Novartis
René P. Buholzer
Delegate of the Board
Interpharma
Myriam DeLeone
General Manager Switzerland – Amgen
Dimitri Gitas
General Manager Switzerland – MSD
Thorsten Hein
Country Division Head, Pharmaceuticals – Bayer
Bairbre Hickie 2
General Manager Switzerland – Takeda
Annette Luther 2
Head External Affairs Switzerland – Roche
Linn Mandahl
Vice President Europe South – AbbVie
Andrea Michael Meyer
Head Global Supply Chain Strategy & Excellence/VP – Sanofi
Max Pahlow 2
Managing Director Switzerland – Janssen/Johnson & Johnson
Florian Saur
Country President Switzerland – AstraZeneca
Florian Schick
President and General Manager Switzerland – Merck
David Traub
Managing Director Pharma Switzerland – Novartis
Anne Mette Wiis Vogelsang 2
CVP and General Manager Switzerland – Novo Nordisk
Legend:
1 Member of the Nomination and Membership Committee
2 Member of the Finance Board Committee